person
Lars H. Lund
In network coverage since October 8, 2026 · 1 story
Network coverage
direct_investments
Ljungström family office co-led AnaCardio's €62.5m Series B with Novo Holdings
Two days earlier the office joined Breye Therapeutics' €67.5m Series A as a new investor, and Novo Holdings was in both rounds.